Literature DB >> 10850856

Modulation of hyperoxia-induced TNF-alpha expression in the newborn rat lung by thalidomide and dexamethasone.

L Lindsay1, S J Oliver, S L Freeman, R Josien, A Krauss, G Kaplan.   

Abstract

The effect of high oxygen concentrations on lungs of neonatal rats was studied. In addition, some oxygen-exposed animals were treated with either dexamethasone or thalidomide. No gross histologic changes were noted in the lungs following exposure to 95% oxygen nor were there changes in the total number or the phenotypic distribution of BAL cells obtained from these lungs compared to lungs from air exposed (control) neonatal rats. The majority of the BAL cells were CD45+ leukocytes (macrophages). However, when BAL cells were exposed to LPS in vitro, TNF-alpha production was higher in cells from rats exposed to 95% oxygen compared to cells from rats exposed to ambient air. In addition, lung TNF-alpha and IL-6 mRNA levels were increased after exposure to 95% oxygen. In the lungs of animals treated with either dexamethasone or thalidomide, TNF-alpha mRNA levels were reduced, while only dexamethasone treatment also reduced IL-6 mRNA levels.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10850856     DOI: 10.1023/a:1007096931078

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  19 in total

1.  TNF alpha gene and protein expression in alveolar macrophages in acute and chronic hyperoxia-induced lung injury.

Authors:  H Horinouchi; C C Wang; K E Shepherd; R Jones
Journal:  Am J Respir Cell Mol Biol       Date:  1996-06       Impact factor: 6.914

2.  Suppression of TNF-alpha mRNA expression in LPS-primed macrophages occurs at the level of nuclear factor-kappa B activation, but not at the level of protein kinase C or CD14 expression.

Authors:  N Takasuka; K Matsuura; S Yamamoto; K S Akagawa
Journal:  J Immunol       Date:  1995-05-01       Impact factor: 5.422

3.  Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers.

Authors:  A H Stolpen; E C Guinan; W Fiers; J S Pober
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

4.  Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions.

Authors:  J C Fantone; P A Ward
Journal:  Am J Pathol       Date:  1982-06       Impact factor: 4.307

5.  Tumor necrosis factor and interleukin 1 alpha increase vascular endothelial permeability.

Authors:  J A Royall; R L Berkow; J S Beckman; M K Cunningham; S Matalon; B A Freeman
Journal:  Am J Physiol       Date:  1989-12

6.  Tumor necrosis factor enhances the neutrophil-dependent increase in endothelial permeability.

Authors:  L S Gibbs; L Lai; A B Malik
Journal:  J Cell Physiol       Date:  1990-12       Impact factor: 6.384

7.  Pulmonary O2 toxicity: role of endogenous tumor necrosis factor.

Authors:  M F Tsan; J E White; P B Michelsen; G H Wong
Journal:  Exp Lung Res       Date:  1995 Jul-Aug       Impact factor: 2.459

8.  Actions of tumor necrosis factor on cultured vascular endothelial cells: morphologic modulation, growth inhibition, and cytotoxicity.

Authors:  N Sato; T Goto; K Haranaka; N Satomi; H Nariuchi; Y Mano-Hirano; Y Sawasaki
Journal:  J Natl Cancer Inst       Date:  1986-06       Impact factor: 13.506

Review 9.  Bronchoalveolar inflammatory pathophysiology of bronchopulmonary dysplasia.

Authors:  J J Zimmerman
Journal:  Clin Perinatol       Date:  1995-06       Impact factor: 3.430

10.  Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes.

Authors:  E P Sampaio; E N Sarno; R Galilly; Z A Cohn; G Kaplan
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

View more
  6 in total

1.  Iloprost attenuates hyperoxia-mediated impairment of lung development in newborn mice.

Authors:  Nelida Olave; Charitharth Vivek Lal; Brian Halloran; Vineet Bhandari; Namasivayam Ambalavanan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-06-28       Impact factor: 5.464

2.  Hyperoxia-derived lung damage in preterm infants.

Authors:  Vineet Bhandari
Journal:  Semin Fetal Neonatal Med       Date:  2010-04-28       Impact factor: 3.926

Review 3.  Postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia.

Authors:  Vineet Bhandari
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2014-02-27

4.  Long-term (postnatal day 70) outcome and safety of intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells in neonatal hyperoxic lung injury.

Authors:  So Yoon Ahn; Yun Sil Chang; Soo Yoon Kim; Dong Kyung Sung; Eun Sun Kim; So Yub Rime; Wook Joon Yu; Soo Jin Choi; Won Il Oh; Won Soon Park
Journal:  Yonsei Med J       Date:  2013-03-01       Impact factor: 2.759

5.  Adult Rat Bone Marrow-Derived Stem Cells Promote Late Fetal Type II Cell Differentiation in a Co-Culture Model.

Authors:  Ab Knoll; T Brockmeyer; R Chevalier; K Zscheppang; Hc Nielsen; Ce Dammann
Journal:  Open Respir Med J       Date:  2013-05-17

6.  Erythropoietin attenuates hyperoxia-induced lung injury by down-modulating inflammation in neonatal rats.

Authors:  Jang Hoon Lee; Dong Kyung Sung; Soo Hyun Koo; Bong Kyung Shin; Young Sook Hong; Chang Sung Son; Joo Won Lee; Yun Sil Chang; Won Soon Park
Journal:  J Korean Med Sci       Date:  2007-12       Impact factor: 2.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.